V020-3477 Screening compound: N-({1-[(3,5-dimethoxyphenyl)methyl]-4-(4-methylphenyl)pyrrolidin-3-yl}methyl)-N-[(4-fluorophenyl)methyl]acetamide

V020-3477 Screening compound: N-({1-[(3,5-dimethoxyphenyl)methyl]-4-(4-methylphenyl)pyrrolidin-3-yl}methyl)-N-[(4-fluorophenyl)methyl]acetamide
V020-3477 Screening compound: N-({1-[(3,5-dimethoxyphenyl)methyl]-4-(4-methylphenyl)pyrrolidin-3-yl}methyl)-N-[(4-fluorophenyl)methyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-3477
N-({1-[(3,5-dimethoxyphenyl)methyl]-4-(4-methylphenyl)pyrrolidin-3-yl}methyl)-N-[(4-fluorophenyl)methyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-3477

Molecular Formula

C30H35FN2O3 (C30 H35 FN2 O3)

Compound Name

N-({1-[(3,5-dimethoxyphenyl)methyl]-4-(4-methylphenyl)pyrrolidin-3-yl}methyl)-N-[(4-fluorophenyl)methyl]acetamide

IUPAC name

N-({1-[(35-dimethoxyphenyl)methyl]-4-(4-methylphenyl)pyrrolidin-3-yl}methyl)-N-[(4-fluorophenyl)methyl]acetamide

SMILES

CC(N(CC(CN(Cc1cc(OC)cc(OC)c1)C1)C1c1ccc(C)cc1)Cc(cc1)ccc1F)=O

InChI

InChI=1S/C30H35FN2O3/c1-21-5-9-25(10-6-21)30-20-32(16-24-13-28(35-3)15-29(14-24)36-4)18-26(30)19-33(22(2)34)17-23-7-11-27(31)12-8-23/h5-15,26,30H,16-20H2,1-4H3

InChI Key

PKLOIWUEXNKRKI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19922522

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

490.62

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.262

Distribution Coefficient, logD

0.275

Water Solubility, LogSw

-5.04

Polar Surface Area

35.699

Acid Dissociation Constant (pKa)

23.27

Base Dissociation Constant (pKb)

12.39

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

36.70

V020-3477 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V020-3477 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-3477?
Check Price and Availability of V020-3477, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-3477 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-3477
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-3477
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-3477 available by request